Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

P

PVLA

Palvella Therapeutics Inc

142.04

Aug 21 • 3:59 PM ET -0.54 (-0.38%)

142.04

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Healthcare Biotechnology USA Mid NASD

Peers: KYMR MANE ORKA RYTM KRYS BMRN CRNX INCY AXSM NBIX

| Held by: XBI VTI IWM VXF IWO VTWO VHT VFMO LFSC LABU

Scroll to Statements

Index	RUT
Market Cap	2.05B
Enterprise Value	1.82B
Income	-61.70M
Sales	0.00M
Book/sh	15.06
Cash/sh	17.39
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	29
IPO	Jan 02, 2015

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	9.43
P/C	8.17
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	21.18
Current Ratio	21.18
Debt/Eq	0.10
LT Debt/Eq	0.10
Option/Short	Yes / Yes

EPS (ttm)	-4.84
EPS next Y	-7.81
EPS next Q	-1.77
EPS this Y	-75.53%
EPS next Y	-19.92%
EPS next 5Y	-11.12%
EPS past 3/5Y	53.08% 41.62%
Sales past 3/5Y	- -
EPS Y/Y TTM	61.66%
Sales Y/Y TTM	-
EPS Q/Q	-77.78%
Sales Q/Q	-
Earnings	Aug 04 BMO
EPS/Sales Surpr.	-29.55% -

Insider Own	36.96%
Insider Trans	-0.35%
Inst Own	88.11%
Inst Trans	33.38%
ROA	-37.70%
ROE	-46.63%
ROIC	-25.78%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-4.98%
SMA50	0.41%
SMA200	23.24%
Trades

Shs Outstand	14.40M
Shs Float	9.08M
Short Float	22.78%
Short Ratio	8.31
Short Interest	2.07M
52W High	161.38 -11.98%
52W Low	48.65 191.96%
Volatility	5.52% 5.60%
ATR (14)	8.92
RSI (14)	44.89
Beta	-0.25
Rel Volume	0.65
Avg Volume	249.00K
Volume	161,872

Perf Week	-9.02%
Perf Month	-0.81%
Perf Quarter	22.53%
Perf Half Y	65.82%
Perf YTD	35.70%
Perf Year	176.83%
Perf 3Y	462.76%
Perf 5Y	-56.05%
Perf 10Y	8.93%
Recom	1.00
Target Price	229.82
Prev Close	142.58
Price	142.04
Change %	-0.38%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)